ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 27, 2017 12:38 JST
Source:
Sisram Medical Ltd
Sisram Medical Ltd Increase in Shareholding by Controlling Shareholder and CEO As a Vote of Confidence and Trust in the Company's Future Success
HONG KONG, Nov 27, 2017 - (ACN Newswire) - Sisram Medical Ltd ("Sisram" or the "Company"; stock code: 1696.HK), an investment holding company specializing in medical technology for healthcare ranked #1 in the PRC and one of the top 5 global leaders in the industry, announced the increase in shareholding by the Company's controlling shareholder and CEO.
Ample Up Limited ("Ample Up"), controlling shareholder of Sisram, and Mr. Lior Moshe Dayan, Chief Executive Officer and Executive Director of Sisram, has acquired additional shares of the Company. According to latest announcements, Ample Up has made on-market purchase on The Stock Exchange of Hong Kong Limited ("SEHK") of an aggregate of 288,800 and 270,000 shares of the Company on 21 and 22 November 2017 respectively. Mr. Dayan has made on-market purchases on SEHK of an aggregate of 36,000 shares of the Company. After the increase in shareholding, Ample Up directly and indirectly controls approximately 52.83% and Mr. Dayan controls approximately 0.008% of the total issued shares of the Company.
In the first half of 2017, the Company's revenue was reported US$66.3 million, representing a year over year growth of 12.9%. The Company's adjusted net profit increased by 30.6% to US$13.3 million. The profitability and operational quality of the Company improved continuously. Sisram invest a lot of efforts in promoting its various brands, increasing market awareness and sales of its products, as well as expanding sales and distribution channels. The increase of shareholdings by the company's controlling shareholder and management expresses a vote of confidence in the company and its future roadmap.
Looking forward, Mr. Lior Moshe Dayan said, "Sisram is the first Israeli company listed on the main board of the Hong Kong Stock Exchange, with comprehensive in-house capabilities to design, develop and produce energy-based medical aesthetic treatment systems. In the past 3 years, more than 90% of our revenue was driven from products that we have developed in-house. Moving forward we are committed to significant investments in Research & Development that will produce innovative high-end products to meet the growing opportunities that the global market of energy-based medical aesthetic treatment solutions presents."
About Sisram Medical Ltd
Sisram Medical Ltd. (1696.HK), the first Israeli company listed on the Hong Kong Stock Exchange Main Board, is an investment holding company specializing in medical technology for healthcare. Among its holdings is Alma Lasers, a leading provider of energy-based surgical and medical aesthetic solutions, rating #1 in the Peoples Republic of China and one of the top 5 global leaders in its industry. Sisram Medical is a subsidiary of Fosun Pharma, a leading health & medical industry group in China.
Sisram Medical - Enhancing Quality of Life.
www.sisram-medical.com
Source: Sisram Medical Ltd
Sectors: Daily Finance, Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
NTT DATA and DENSO Sign a Basic Agreement on Strategic Partnership for Software
Jun 13, 2024 18:01 JST
Honda and MC to Establish New Company, ALTNA Co., Ltd.
Jun 13, 2024 17:18 JST
Honda to Begin Sales of New N-VAN e: Commercial-use Mini-EV in Japan
Jun 13, 2024 16:04 JST
JCB and iMago Launch "Chikazuite-Check" Project to Provide a New Buying Experience
Jun 13, 2024 14:00 JST
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
Jun 12, 2024 11:00 JST
FDA Accepts Eisai's Filing of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Jun 10, 2024 18:50 JST
Yuki Tsunoda to Continue Competing in F1 for the 2025 Season with VISA Cash App RB Formula One Team
Jun 10, 2024 12:37 JST
Honda Advances Hydrogen Strategy with Production Launch of Fuel Cell Electric Vehicle in Ohio
Jun 07, 2024 18:29 JST
Le Mans awaits TOYOTA GAZOO Racing
Jun 07, 2024 16:56 JST
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of New LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY GREEN in Shimonoseki
Jun 07, 2024 16:38 JST
MHIEC Receives Order to Rebuild Waste-to-Energy Plant in Hodogaya Ward, Yokohama
Jun 06, 2024 19:34 JST
MHI Thermal Systems Launches New "TEK Series" of Electric-Driven Transport Refrigeration Units for Small and Mid-Size Trucks
Jun 06, 2024 12:20 JST
MHI and EGAT sign MoU to Introduce Hydrogen Large Gas Turbine Co-firing Technology in Thailand to Achieve Net Zero Goals
Jun 05, 2024 19:09 JST
Mitsubishi Shipbuilding Receives Additional Order for 2 Units of LNG Fuel Gas Supply System (FGSS)
Jun 05, 2024 18:14 JST
NEC announces external appointment of executive personnel
Jun 05, 2024 17:43 JST
JCB collaborates with Singapore's Mandai Wildlife Group to promote wildlife park visitorship
Jun 05, 2024 12:00 JST
Hitachi and Microsoft Enter Milestone Agreement to Accelerate Business and Social Innovation with Generative AI
Jun 04, 2024 14:45 JST
Japan Energy Summit & Exhibition 2024 Unites Global Leaders to Propel Asia's Emergence in Climate Leadership
Jun 04, 2024 11:09 JST
Fujitsu to provide the world's first enterprise-wide generative AI framework technology to meet changing needs of companies
Jun 04, 2024 10:47 JST
JCB and Bank Mandiri Launch Japan Festival Program Campaign
Jun 04, 2024 10:00 JST
More Latest Release >>
Related Release
Sisram Med Presents its Best Annual Reports to Date
March 21 2018 08:30 JST
The New ALMA BEAUTY SPADEEP Platform Launched Globally After Receiving Outstanding Feedbacks in the Japanese Market
December 06 2017 16:34 JST
Sisram Med Revenue in First Half 2017 Increased 12.9% to US$66.3 Million
September 29 2017 18:31 JST
Net Proceeds of approximately HK$877.2 Million from Global Offering; Sisram Med Trading Debut on SEHK on 19 September 2017
September 20 2017 12:57 JST
Sisram Med Successfully Listed on Main Board of SEHK
September 20 2017 12:34 JST
Sisram Medical Offers price between HK$8.88 and HK$12.35 per share
September 05 2017 17:00 JST
More Press release >>